Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

from The Biopharma Pod · host William Reed Ltd

Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Episode metadata supplied by the publisher feed · Published Jul 16, 2013

Embed this episode

Attribution link and audio player

Ready to play

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

0:00 5:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 5 minutes long.

This episode was published on July 16, 2013.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!